What You Should Know: - FDA awards AppliedVR Breakthrough Device designation for treating treatment-resistant fibromyalgia and chronic intractable lower back pain - AppliedVR’s EaseVRx program helps patients learn self-management skills grounded in evidence-based cognitive-behavioral therapy (CBT) principles and other behavioral methods. AppliedVR, a pioneer advancing the next generation of digital medicine, today announced its EaseVRx product received Breakthrough Device designation
Read More
NIH
NIH Funds First Nationwide Rare and Atypical Diabetes Network
What You Should Know: - NIH awards funding for Rare and Atypical Diabetes Network, or RADIANT that will seek to discover the cause of several unusual forms of diabetes. - RADIANT plans to screen about 2,000 people with unknown or atypical forms of diabetes that do not fit the common features of type 1 and type 2 diabetes. The National Institute of Health (NIH), announced this week it is funding a nationwide study with The Rare and Atypical Diabetes Network (RADIANT) that will seek
Read More
NIH Taps PhysIQ to Develop AI-Based COVID-19 Digital Biomarker
What You Should Know: - physIQ has been selected by the National Institute of Health (NIH) to develop an innovative AI-based COVID-19 digital biomarker solution to address the COVID-19 pandemic. - Early detection of COVID-19 decompensation in patients is complicated by infrequent and non-specific clinical data. The first-in-kind tool will collect and analyzes continuous physiologic data could provide early clinical indicators of COVID-19 decompensation. The National Cancer Institute
Read More
Scanwell Health Nabs $1.6M NIH Grant for its Rapid, At-Home Test for Chronic Kidney Disease
What You Should Know: - LA-based health tech startup Scanwell Health announced today that it has received a $1.6M NIH grant to accelerate the development of its rapid at-home test for Chronic Kidney Disease (CKD). - CKD can be a silent killer - most people who have it are unaware until it's too late to treat effectively. But if diagnosed early, disease progression can be slowed. - An early version of Scanwell's rapid at-home test is being used by researchers at several leading
Read More
Talis Awarded $25M NIH Contract for Point-of-Care COVID-19 Testing
What You Should Know: - Today, Talis Biomedical Corporation announced it has been awarded a $25M contract from the National Institutes of Health (NIH) as part of Phase 2 of its Rapid Acceleration of Diagnostics (RADx) initiative as well as another $100 million in additional financing. - The new funding will be used to scale manufacturing for the launch of the Talis One™ diagnostic platform that provides rapid and highly accurate detection of COVID-19 at points-of-care in 30 minutes
Read More
Ciox Health Acquires Biomedical NLP Company Medal
What You Should Know: - Ciox Health has acquired Medal, Inc., a biomedical Natural Language Processing (biomed-NLP) technology company. - The acquisition will lead Ciox to better and more quickly enable real-world data in support of research that advances patient care. Ciox Health, a leading health technology company, today announced its acquisition of San Francisco-based biomedical Natural Language Processing (biomed-NLP) technology company, Medal, Inc., a leader in
Read More
Eko Awarded $2.7M NIH Grant for Heart Murmur & Valvular Heart Disease Detection Algorithms
What You Should Know: - The National Institutes of Health (NIH) has granted next-generation cardiac AI company Eko an award totaling $2.7 million to support continued collaborative work with Northwestern Medicine Bluhm Cardiovascular Institute - The grant will focus on validating algorithms and help more accurately screen for heart murmurs and valvular heart disease during routine office visits with Northwestern Medicine. - By incorporating data from tens of thousands of
Read More
HHS Taps Fenway Health as Pilot Site for Precision Medicine Project
What You Should Know: - Fenway Health has been selected as the pilot site to participate in the Advancing Standards for Precision Medicine (ASPM) project. - The ASPM project is focused on how healthcare providers can systematically identify the socio-economic factors that may impact the health of patients in order to provide more individualized care that reflects patients’ needs. Fenway Health, a Boston, MA-based Federally Qualified Community Health Center (FQCHC)
Read More
5 Reasons Why Providers Need Electronic Support for Glycemic Management
It’s no secret hyperglycemia and hypoglycemia are associated with adverse outcomes in hospitalized patients. We’ve known for many years that hyperglycemia is widespread in the hospital, causes immune dysfunction, higher rates of infection, a longer length of hospital stay, complications, and even death. Insulin has been the most effective therapy for hyperglycemia since it was first created almost 100 years ago, but it can also be dangerous if not managed properly. In fact, nearly 50% of all
Read More
Cleveland Clinic Awarded $7.2M NIH Grant for to Study MRI-Based Biomarker in Multiple Sclerosis
What You Should Know: - Cleveland Clinic-led research team has been awarded a $7.2M grant from the National Institutes of Health (NIH) to support a multi-center study to study CVS, an MRI-based biomarker identified in multiple sclerosis associated white matter lesion. - The prospective study, referred to as CAVS-MS, will enroll 400 patients with typical or atypical presentations of MS at 11 participating centers in North America, with Cleveland Clinic serving as
Read More